Melissa Hoffman

机构：Vividion Therapeutics (United States) · ORCID：0000-0002-4682-8861

发表论文 46 篇 · 总被引 1554 次 · h-index 19

代表论文

• The Science Performance of JWST as Characterized in Commissioning (2023 · Publications of the Astronomical Society of the Pacific · 被引 433)
• Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase (2024 · Nature · 被引 111)
• Driving Performance and Cannabis Users’ Perception of Safety (2022 · JAMA Psychiatry · 被引 97)
• Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke (2024 · New England Journal of Medicine · 被引 63)
• Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath (2021 · Journal of Analytical Toxicology · 被引 38)
• Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats (2021 · Psychopharmacology · 被引 30)